Piramal Enterprises Ltd.

NSE: PEL  SECTOR: Pharmaceuticals & Drugs

1651
-68.5 (-3.98%)

Price Summary

Today's High

₹ 1700

Today's Low

₹ 1628.45

52 Week High

₹ 2008.2

52 Week Low

₹ 805.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

37236.371679 Cr.

Enterprise Value

47733.151679 Cr.

No. of Shares

22.553829 Cr.

P/E

0

P/B

1.66

Face Value

₹ 2

Div. Yield

0.85%

Book Value (TTM)

₹  994.4439

CASH

78.74 Cr.

DEBT

10575.52 Cr.

Promoter Holding

46.06%

EPS (TTM)

₹  -23.193

Sales Growth

14.9376847324189%

ROE

0.68786748495275 %

ROCE

6.41152689890439 %

Profit Growth

3.43312341942411 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year14.94%
3 Year3.86%
5 Year11.93%

Profit Growth (in Cr.)

1 Year116.69%
3 Year-42.87%
5 Year-17.22%

ROE%

1 Year0.69%
3 Year-0.22%
5 Year2.65%

ROCE %

1 Year6.41%
3 Year4.69%
5 Year6.16%

Debt/Equity

0.4674

Price to Cash Flow

32.85

Interest Cover Ratio

1.31568482977205

CFO/PAT (5 Yr. Avg.)

NA

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2021 46.06 0
Dec 2020 46.06 0
Sep 2020 46.06 0
Jun 2020 46.06 0
Mar 2020 46.06 0
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 6912.02 Cr.
  • The Company has been maintaining an effective average operating margins of 40.6244739356393% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -17.5854128459823 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.67264801486639.

 Limitations

  • The company has shown a poor profit growth of -42.8687813283517% for the Past 3 years.
  • The company has shown a poor revenue growth of 3.85837351148095% for the Past 3 years.
  • Company has a poor ROE of -0.22158694957008% over the past 3 years.
  • Company has a poor ROCE of 4.69386937300332% over the past 3 years
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 30.1368.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
Net Sales 915.67 988.71 817.41 1026.45 563.08
Total Expenditure 538.03 955.32 500.28 576.41 222.9
Operating Profit 377.64 33.39 317.13 450.04 340.18
Other Income 153.1 289.06 38.52 92.71 22.85
Interest 376.51 388.93 287.92 345.95 254.02
Depreciation 41.53 51.96 40.67 38.14 8.7
Exceptional Items 0 0 0 -37.42 -258.35
Profit Before Tax 112.7 -118.44 27.06 121.24 -158.04
Tax 75.98 365.84 4.52 17.93 6.62
Profit After Tax 36.72 -484.28 22.54 103.31 -164.66
Adjusted EPS (Rs) 0.18 -2.15 0.1 0.46 -0.73

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 3384.35 3766.21 3288.63 3670.85 4219.19
Total Expenditure 2076.38 2153.98 2076.5 2013.58 2502.38
Operating Profit 1307.97 1612.23 1212.13 1657.27 1716.81
Other Income 471.92 580.53 642.45 461.57 708.55
Interest 786.88 1178.34 989.55 1497.27 1710.06
Depreciation 79.55 94.49 111.58 131.22 175.46
Exceptional Items 70.19 0 0 -1287.96 0
Profit Before Tax 983.65 919.93 753.45 -797.61 539.84
Tax -12.05 143.15 234.98 70.4 394.99
Net Profit 995.7 776.78 518.47 -868.01 144.85
Adjusted EPS (Rs.) 56.01 43.69 28.08 -45.94 6.42

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 34.51 34.51 36.05 36.89 45.11
Total Reserves 12766.1 14388.09 21300.8 19455.04 22582.87
Borrowings 5633.23 2739.52 4011.56 4619.83 2389.78
Other N/C liabilities 4016.96 4150.47 4487.13 4599.97 4626.66
Current liabilities 8792.28 8427.57 11426.64 13786.19 9635.95
Total Liabilities 31243.08 29740.16 41262.18 42497.92 39280.37
Assets
Net Block 954.44 1074.8 1807.19 1823.9 1789.26
Capital WIP 91.76 575.21 77.18 45.91 62.8
Investments 17425.78 15607.64 20867.45 22044.81 18452.21
Loans & Advances 9170.12 8392.15 13440.31 15556.69 15797.95
Other N/C Assets 83.8 45.71 61.25 57.89 57.53
Current Assets 3517.18 4044.65 5008.8 2968.72 3120.62
Total Assets 31243.08 29740.16 41262.18 42497.92 39280.37
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 913.46 919.93 753.45 490.35 539.84
Adjustment 79.59 -56.05 -41.23 149.73 346.39
Working Capital Changes -7799.39 -7022.94 -5446.85 6285.52 310.83
Tax Paid -289.1 -188.62 -175.84 -178.73 -63.55
Operating Cash Flow -7130.93 -6347.68 -4910.47 6746.87 1133.51
Investing Cash Flow -1440.25 -2424.41 -4403.39 -9328.91 1886.88
Financing Cash Flow 8555.87 8887.2 9690.02 2068.67 -4543.56
Net Cash Flow -15.31 115.11 376.16 -513.37 -1523.17

Corporate Actions

Company Presentations

Company News

Piramal Enterprises Stock Price Analysis and Quick Research Report. Is Piramal Enterprises an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Piramal Enterprises and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 1133.51 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Piramal Enterprises has a Debt to Equity ratio of 0.4674 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Piramal Enterprises , the EPS growth was 113.646805278741 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Piramal Enterprises has OPM of 40.6905116858923 % which is a good sign for profitability.
     
  • ROE: Piramal Enterprises have a poor ROE of 0.68786748495275 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Piramal Enterprises

X